Fixed-dose combination (antiretroviral)
Fixed-dose combinations of antiretrovirals are multiple antiretroviral drugs combined into a single pill, which helps reduce pill burden. They may combine different classes of antiretrovirals (e.g., Atripla) or contain only a single class (e.g., Epzicom). Licensed fixed-dose combinations are shown in the table below. Some are complete single-tablet regimens for the management of HIV/AIDS (the drug is one pill taken once daily); the others must be combined with one or more additional pills to complete a regimen.
| Brand name(s) | Ingredients (INN) | FDA approval date | Company | Single-tablet regimen? | ||||
| NRTIs / NtRTIs | NNRTI | INSTI | PI | PK enhancer | ||||
| Combivir | lamivudine zidovudine |
September 26, 1997 | ViiV Healthcare | No | ||||
| Kaletra (developed countries) Aluvia (developing countries) |
lopinavir | ritonavir | September 15, 2000 | Abbott Laboratories | No | |||
| Trizivir | abacavir lamivudine zidovudine |
November 15, 2000 | ViiV Healthcare | Yes | ||||
| Epzicom (US) Kivexa (EU, RU) |
abacavir lamivudine |
August 2, 2004 | ViiV Healthcare | No | ||||
| Generics, e.g., Triomune | lamivudine stavudine |
nevirapine | (not approved) | (many companies) | Yes | |||
| Generics, e.g., Duovir-N | lamivudine zidovudine |
nevirapine | (not approved) | (many companies) | Yes | |||
| Truvada | emtricitabine tenofovir disoproxil |
August 2, 2004 | Gilead Sciences | No | ||||
| Atripla | emtricitabine tenofovir disoproxil |
efavirenz | July 12, 2006 | Gilead Sciences Bristol-Myers Squibb |
Yes | |||
| Complera (US) Eviplera (EU, RU) |
emtricitabine tenofovir disoproxil |
rilpivirine | August 10, 2011 | Gilead Sciences Janssen Pharmaceutica |
Yes | |||
| Stribild | emtricitabine tenofovir disoproxil |
elvitegravir | cobicistat | August 27, 2012 | Gilead Sciences | Yes | ||
| Triumeq | abacavir lamivudine |
dolutegravir | August 22, 2014 | ViiV Healthcare | Yes | |||
| Evotaz | atazanavir | cobicistat | January 29, 2015 | Bristol-Myers Squibb | No | |||
| Prezcobix (US) Rezolsta (EU) |
darunavir | cobicistat | January 29, 2015 | Janssen Pharmaceutica | No | |||
| Dutrebis | lamivudine | raltegravir | February 6, 2015 | Merck & Co. | No | |||
| Genvoya | emtricitabine tenofovir alafenamide |
elvitegravir | cobicistat | November 5, 2015 | Gilead Sciences | Yes | ||
| Odefsey | emtricitabine tenofovir alafenamide |
rilpivirine | March 1, 2016 | Gilead Sciences | Yes | |||
| Descovy | emtricitabine tenofovir alafenamide |
April 4, 2016 | Gilead Sciences | No | ||||
| Juluca | rilpivirine | dolutegravir | November 21, 2017 | ViiV Healthcare | Yes | |||
| Symfi, Symfi Lo | lamivudine tenofovir disoproxil |
efavirenz | February 5, 2018 (Symfi Lo) March 22, 2018 (Symfi) |
Mylan | Yes | |||
| Biktarvy | emtricitabine tenofovir alafenamide |
bictegravir | February 7, 2018 | Gilead Sciences | Yes | |||
| Cimduo | lamivudine tenofovir disoproxil |
February 28, 2018 | Mylan | No | ||||
| Symtuza | emtricitabine tenofovir alafenamide |
darunavir | cobicistat | July 17, 2018 | Janssen Pharmaceutica | Yes | ||
| Delstrigo | lamivudine tenofovir disoproxil |
doravirine | August 30, 2018 | Merck & Co. | Yes | |||
| Dovato | lamivudine | dolutegravir | April 8, 2019 | ViiV Healthcare | Yes | |||
See also
References
This article is issued from
Wikipedia.
The text is licensed under Creative
Commons - Attribution - Sharealike.
Additional terms may apply for the media files.